Callahan Thompson Sherman & Caudill LLP – Trademark Portfolio

Entity Type: 99

Callahan Thompson Sherman & Caudill LLP holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 45 (Legal & Security Services) — 3 filings in this category. Currently, 1 trademark is registered. Notable registered marks include ECAP EARLY CASE ASSESSMENT PROGRAM. The owner is based in Irvine, CA.

2601 Main Street, Suite 800

Irvine, CA 92614

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Callahan Thompson Sherman & Caudill LLP's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

45
Legal & Security Services (3 filings)

Legal services; security services for the protection of property and individuals

Frequently Asked Questions

How many trademarks does Callahan Thompson Sherman & Caudill LLP have?

Callahan Thompson Sherman & Caudill LLP has 3 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 abandoned, 1 cancelled.

What trademark classes does Callahan Thompson Sherman & Caudill LLP file in?

Callahan Thompson Sherman & Caudill LLP files trademarks across 1 Nice Classification class. The most active classes are Class 45 (Legal & Security Services). Class 45 covers legal services; security services for the protection of property and individuals.

What are Callahan Thompson Sherman & Caudill LLP's most well-known trademarks?

Callahan Thompson Sherman & Caudill LLP's registered trademark portfolio includes well-known marks such as ECAP EARLY CASE ASSESSMENT PROGRAM. These are among 1 currently registered trademark in the portfolio.

What is Callahan Thompson Sherman & Caudill LLP's trademark registration success rate?

Callahan Thompson Sherman & Caudill LLP has a 33% trademark registration rate, with 1 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.